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Abstract
Infectious salmon anaemia virus (ISAV) is an orthomyxovirus causing a multisystemic, emerging disease in Atlantic salmon. Here we
present, for the first time, detailed sequence analyses of the full-genome sequence of a presumed avirulent isolate displaying a full-length
hemagglutinin-esterase (HE) gene (HPR0), and compare this with full-genome sequences of 11 Norwegian ISAV isolates from clinically
diseased fish. These analyses revealed the presence of a virulence marker right upstream of the putative cleavage site R267 in the fusion (F)
protein, suggesting a Q266→L266 substitution to be a prerequisite for virulence. To gain virulence in isolates lacking this substitution, a sequence
insertion near the cleavage site seems to be required. This strongly suggests the involvement of a protease recognition pattern at the cleavage site
of the fusion protein as a determinant of virulence, as seen in highly pathogenic influenza A virus H5 or H7 and the paramyxovirus Newcastle
disease virus.
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Proteolytic cleavage siteIntroduction
Infectious salmon anaemia virus (ISAV) is an orthomyx-
ovirus causing a multisystemic emerging disease in Atlantic
salmon (Salmo salar). Natural outbreaks of infectious salmon
anaemia (ISA) were reported for the first time in Norway in
1984 (Thorud and Djupvik, 1988) and it was considered a
unique Norwegian disease problem for over 10 years. However,
in 1996 a disease condition (hemorrhagic kidney syndrome) in
Canadian farmed salmon turned out to be caused by ISAV⁎ Corresponding author. Fax + 47 22 96 48 18.
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the disease was diagnosed in Scotland (Rodger and Richards,
1998), the Shetland Islands, the Faroe Islands and USA (Bou-
chard et al., 1999). Isolation of ISAV from a disease outbreak
in Coho salmon (Oncorhynchus kisutch) from Chile has been
reported (Kibenge et al., 2001). The presence of ISAV in Chile
was officially verified in 2006, and recently an ISA disease
outbreak was officially confirmed in Atlantic salmon (http://
www.oie.int/eng/en_index.htm).
The morphological, physiochemical and genetic properties
of ISAV are consistent with those of the Orthomyxoviridae
(Mjaaland et al., 1997; Falk et al., 1997), where ISAV is
classified as the type species of a new genus Isavirus (Kawaoka
et al., 2005) within this family. Present knowledge indicates that
wild salmonids represent important natural reservoirs for ISAV.
Natural disease outbreaks have only been described in farmed
Atlantic salmon, although ISAV has been demonstrated both in
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Raynard et al., 2001; Cunningham et al., 2002; MacLean et al.,
2003) and the virus may, under experimental conditions, persist
and replicate in other salmonid (Salvelinus alpinus, Oncor-
hynchus mykiss, Oncorhynchus keta, Oncorhynchus kisutch)
(Snow et al., 2001; Rolland and Winton, 2003; Nylund et al.,
1995, 1997) and non-salmonid fish (Clupea harengus, Gadus
morhua) (Nylund et al., 2002; Grove et al., 2007).
As in influenza A and B viruses, the ISAV genome consists
of eight negative sense, single-stranded RNA segments
encoding at least 10 proteins (Mjaaland et al., 1997; Falk
et al., 2004; Clouthier et al., 2002), although the organization of
ISAV genes and gene products is unique. The functional
organization of the two major ISAV surface glycoproteins
differs from influenza A and B viruses; the ISAV hemagglu-
tinin-esterase (HE) encoded by segment 6 is responsible for
receptor-binding and release (Falk et al., 2004; Krossøy et al.,
2001; Rimstad et al., 2001), while the segment 5 encoded fusion
(F) protein is responsible for fusion of viral and cellular
membranes (Aspehaug et al., 2005). For influenza A and B
however, the receptor-binding and fusion functions reside in the
hemagglutinin (HA) while receptor-destroying activity resides
in the neuraminidase (NA) (Colman et al., 1983; Palese et al.,
1974; Wiley and Skehel, 1977, 1987). The viral polymerases
(PB2, PB1 and PA) are encoded by segments 1, 2, and 4
(Clouthier et al., 2002; Krossøy et al., 1999; Snow et al., 2003),
while segment 3 encodes the nucleoprotein (NP) (Aspehaug
et al., 2004; Snow and Cunningham, 2001). At least two
proteins are encoded from each of the two smallest genomic
segments: the un-spliced mRNA of segment 7 produces a non-
structural protein with interferon antagonistic properties (Bier-
ing et al., 2002; McBeath et al., 2006; García-Rosado et al., in
press), while ORF2 is suggested to encode for a nuclear export
protein (Kibenge et al., 2007). The presence of a third ORF has
also been suggested (Kibenge et al., 2007). From segment 8, the
matrix protein is produced from the smaller ORF1 (Biering
et al., 2002; Falk et al., 2004), while the larger ORF2 encodes an
RNA binding structural protein with interferon antagonistic
properties (García-Rosado et al., in press).
The HE surface glycoprotein is the molecule with the highest
sequence variability and assumed to be of importance in
virulence (Mjaaland et al., 2002, 2005; Devold et al., 2001;
Cunningham et al., 2002; Nylund et al., 2007). Most of the
variation in this molecule is, however, concentrated to a small
highly polymorphic region (HPR) near the transmembrane
domain (Krossøy et al., 2001; Cunningham et al., 2002;
Rimstad et al., 2001; Devold et al., 2001; Mjaaland et al., 2002),
suggested to result from differential deletions of a full-length
avirulent precursor gene (HPR0) resulting in more or less
pathogenic viruses, possibly as a consequence of transmission
from a viral reservoir to densely populated farmed Atlantic
salmon (Mjaaland et al., 2002). In fact, the presence of ISAV
HPR0 isolate has been confirmed in healthy wild and farmed
Atlantic salmon (Cunningham et al., 2002; Cook-Versloot et al.,
2004; Anonymous, 2005; Nylund et al., 2007). HPR0 has not
been detected in diseased fish with classical clinical and
pathological changes consistent with ISA. Occasionally, how-ever, detection of HPR0 has been associated with signs of
proliferative gill inflammation (PGI) (Anonymous, 2005;
Nylund et al., 2007). The possibility that these clinical signs
could represent a new manifestation of ISA cannot be ruled out,
and based on the lack of adequate experimental infection
models with HPR0 virus, one should be careful to state that
HPR0 is avirulent. However, circumstantial evidence indicates
that infection with HPR0 virus in itself poses a lesser risk of
disease outbreak than infection with ISAV from other HPR
groups. All HE-HPRs described till today can be derived from
a full-length HPR0 sequence, and virus isolated from ISA-
diseased fish always contains a deletion in this region
(Mjaaland et al., 2002; Nylund et al., 2007) (www.mattilsy-
net.no). The driving forces behind the differential deletion
patterns in the ISAV HE could be analogous to a phenomenon
described for influenza A NA, where varying lengths of the
stalk region has been reported, a property that has been
associated to host range adaptation (Air et al., 1990; Castrucci
and Kawaoka, 1993).
For both avian influenza A virus and paramyxovirus New-
castle disease virus, mutations in proteolytic cleavage sites in
HA0 and F, respectively, are important for virulence (reviewed in
Steinhauer, 1999; Peeters et al., 1999; Gotoh et al., 1992;
Glickman et al., 1988). For instance, in avian influenza A virus
HA of the subtypes H5 and H7, sequential insertion of several
basic amino acid residues at the proteolytic cleavage site leads to
systemic infection and multi-organ failure in poultry (Bosch
et al., 1981; Senne et al., 1996). Several ISAV isolates have been
reported to contain variations in their F gene caused by insertions
near the putative cleavage site of the molecule (Devold et al.,
2006). Whether these insertions lead to analogous alterations in
the cleavage specificity of the virus, with potential changes in
tissue or organ tropism, is not known.
The combination of surface molecules and the internal pro-
teins might have unpredictable influence on the virulence and
pathogenicity of a virus (Tumpey et al., 2005). The evolution of
influenza viruses arises mainly through antigenic drift, where
mutations results in the seasonal variation, and antigenic shift;
the reassortment of gene segments with the possible emergence
of new virulent strains (Desselberger et al., 1978; Li et al., 2004;
Lindstrom et al., 1998; Matsuzaki et al., 2003; McCullers et al.,
2004; Webster et al., 1982). Only a few examples of recom-
bination have been reported (Khatchikian et al., 1989; Orlich
et al., 1994; Hirst et al., 2004; Bergmann et al., 1992; Wagner
et al., 2001; Fields and Winter, 1982; Jennings et al., 1983). In
three of the cases recombination involves an insertion in the
HA gene of influenza A subtype H7 near the cleavage site of
the protein (Khatchikian et al., 1989; Orlich et al., 1994; Hirst
et al., 2004). The detailed mechanisms driving the evolution of
ISAV are not known, although there are reports suggesting that
both reassortment and recombination might be of importance
(Devold et al., 2006).
Here we present phylogenetic and sequence analyses of all
coding regions of 12 Norwegian ISAV isolates, including the
low- or avirulent HPR0 genotype, giving us an opportunity to
map several molecular mechanisms behind the evolution of this
virus. In particular, a new marker for virulence was identified at
517T. Markussen et al. / Virology 374 (2008) 515–527position 266 in the F protein, right upstream of one of the
putative cleavage sites, R267, suggesting involvement of a
protease recognition pattern as a determinant of virulence.
Results
The full-genome sequence of 12 different ISAV isolates
known to vary in virulence was analysed, in order to understand
some of the molecular mechanisms behind the evolution of
ISAV, i.e. a) to determine the genetic relationships between
different ISAV isolates and b) uncover the presence of potential
virulence traits in the ISAV genome. In light of the large
differences in virulence, the ISAV genome was highly con-
served, with pair wise nucleotide sequence identities ranging
from 89.0 to 99.7%, and amino acid identities between 92.3 and
99.5% (Fig. 1). For all gene segments, at least 50% of the amino
acid substitutions led to different amino acid changes. The
highest sequence variation was within the HPR region of the HE
gene (Fig. 1). A relatively high nucleotide sequence variation
was found for segments 5 and 4 as well. Interestingly, most of
the variation between segment 4 sequences could be ascribed to
45 nucleotides shared only between three of the isolates; ISAV5,
ISAV11 and SK779/06 (HPR0 genotype), none of these leading
to changes in amino acids (Fig. 1). Least sequence variation was
found in the two smallest genomic segments, 7 and 8. On the
other hand, a significantly higher proportion of these leads toFig. 1. ISAV genome sequence variation. Nucleotide and amino acid differences in
bottom of each segment, varies only in segment 5 and 6. Each vertical line represents
position and sequences of the HE-HPR, aligned according to their deletion patterns,
shown. Red/blue/green lines represent nucleotide sequence differences leading to ch
were used. Red lines represent changes only in their ORF1, blue lines changes
respectively.changes in amino acids. This was particularly true for segment 7
ORF1 and segment 8 ORF2, each containing 11 amino acid
differences, while in their alternative ORFs, this number was 5
and 2, respectively. Only in one case in each of these two gene
segments did a nucleotide produce an amino acid change in both
their ORFs (Fig. 1).
The results from the phylogenetic analyses performed
separately for each gene segment are presented in Fig. 2A.
Several isolates diverging in virulence clustered together in
several segments with high bootstrap support (ISAV5 and
ISAV11 in segments 1, 2, 3, 4 and 7, and ISAV4 and ISAV10 in
segments 1, 2, 4, 6, 7 and partially in segment 5) (Fig. 2A).
Furthermore, a common ancestor is suggested for segment 6 in
ISAV6, ISAV5 and ISAV3, but not ISAV11. An analogous
situation was observed in segment 5 for the cluster containing
ISAV8, ISAV10, ISAV11 and SK779/06, while here ISAV5 was
excluded. Segment 3 from ISAV4 and ISAV10 was placed in
separate clusters, supporting reassortment of this gene segment
as well. Similarly, analyses of ISAV1 suggest reassortment
events involving segments 2 and 4 (Fig. 2A). In segment 5, the
monophyletic group formed by ISAV8/ISAV10/ISAV11/
SK779/06 had strong support (Fig. 2A). Three nucleotides,
shared only by these four isolates, lead to changes in amino acids
in the F protein when compared to ISAV5 (Table 1), where two
of these located in close proximity to one of the two putative
cleavage sites of this protein, R267 (Aspehaug et al., 2005). Weeach of the eight gene segments. The size of the coding region, shown at the
a positional nucleotide difference according to the reference isolate ISAV9. The
and the placement of the 10 amino acid insert in the ISAV3 F protein, are also
ange in amino acid. For segments 7 and 8 the sequences covering both ORF's
only in their ORF2, and green lines amino acid change in both their ORFs,
Fig. 2. ISAV gene reassortment. A) Phylogenetic analyses were performed using the coding sequences from all eight gene segments. The HPR region in gene segment
6 (HE) and the 30 nucleotide insert in segment 5 (F) of ISAV3 were not included in the analyses. The nucleotide sequences covering both ORF's of segment 7 and 8
were used. Phylogenetic trees were constructed by maximum likelihood (ML) using PHYML, the GTR model of nucleotide substitution and rooted to ISAV9.
Bootstrap values were calculated from 100 replicas using the neighbour-joining method and the F84 model of nucleotide substitution. Isolates' gene segments shown
in blue, green, red or orange differ significantly from that of ISAV9, and are depicted to have arisen from a common origin. The same colour coding, as well as the
prerequisites for the conclusions, are detailed in panel B and its legends. B) Genetic relationship between ISAV gene segments. The data is based both on results from
phylogeny, using bootstrap values above 80, and direct sequence analyses. Lower bootstrap values were accepted in cases were the common origins, or reassortment,
of gene segments had the additional support from detailed sequence analyses. Gene segments likely to share common origins are drawn in the same colour. Dotted
lines = relationship between gene segments is not known.
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Table 1
Comparisons of amino acid differences in selected pairs of ISAV isolates differing in virulence
aThe highly virulent ISAV1 isolate versus the low- or avirulent HPR0 genotype SK779/06.
bOne high (ISAV2) and one low-virulent isolate (ISAV9).
cTwo isolates (ISAV1 and ISAV11) inducing different types of immune responses.
dTwo isolates (ISAV4 and ISAV7) sharing identical HE-HPR's.
eSequence differences in the HE-HPR regions are not included in these comparisons.
Red = amino acid differences unique to the HPR0 genotype. Orange = amino acid differences found only in the low- or avirulent isolates ISAV8, ISAV10, ISAV11
and SK779/06 (shown in same colour as in Fig. 2A for comparisons). Blue = the Q266/L266 virulence marker. “ = identical protein sequences.
Virulence- and immune response data for the selected ISAVs are from Mjaaland et al. (2005).
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results from phylogeny and sequence analyses are summarized
in Fig. 2B.
In one isolate (ISAV3), a 30 nucleotide long insertion,
resulting in the in-frame insertion of 10 amino acids, was found
in segment 5 close to one of the putative cleavage sites
(Fig. 3A). This inserted stretch was almost identical to a
nucleotide sequence close to the 5′ end of the same gene.
Sequence analyses at the insertion site revealed extensive
sequence identity between the sequence surrounding the site of
the insertion, and the 5′ and 3′-ends of the inserted nucleotide
stretch itself (Fig. 3A), consistent with a sequence-based non-
homologues replicase-driven recombination event. Phylogen-
etically, the ISAV3 F gene clustered with a contemporary isolate
from 1989, isolated from a disease outbreak in the same
geographical region (N5/89, Acc. no. AY853957) (Fig. 3B).
These two isolates were identical in their HE gene sequences,
including their HPR regions, and in their F gene (data not
shown), except for a) the amino acid in position 266, which in
the contemporary isolate was a leucine (L), as compared to a
glutamine (Q) in ISAV3, and b) the presence of an insertion in
ISAV3. In fact, in this study the Q266 amino acid right upstream
of the putative R267 cleavage site was only shared between
ISAV3 and the low- or avirulent HPR0 genotype, while in all
the remaining 10 isolates (ISAV1, 2, 4–11) the amino acid in
this position was L266 (Fig. 3A). Blast searches of all availablewhole or partial segment 5 sequences (57 in total) showed either
a L266, Q266, or, in one case, H266, at this position in the protein.
None of the L266, but all of the Q266/H266 containing sequences
had an insertion around the R267 cleavage site, at position 268 or
at position 264 (H266 type only), except for one sequence from
an isolate, where a Q266 was present in an F protein not
containing insertion, (SF83/04, Acc. no. AY744392). However,
this most likely represents a mixed infection of viruses with
HPR0 and that of another HPR genotype, as two accession
numbers are assigned for its HE gene, including a full-length
HPR0 sequence.
For the isolates ISAV1–11 information on disease suscept-
ibility and induced immune responses was available from a
previously performed experimental trial (Mjaaland et al., 2005)
while only field data were available for the HPR0 genotype
SK779/06, as all efforts to culture this isolate have failed. In
attempts to define candidate genes and areas of genes of
importance in ISAV virulence, and in lack of a reverse genetics
system for this virus, the clinical information was coupled with
extended amino acid sequence analyses. These searches
revealed that only eight amino acids were unique for the
HPR0 isolate (Table 1, Fig. 1). Apart from the variation in the
HPR region, there was only a very limited number of overall
amino acid sequence variation between the highly virulent
isolate ISAV1 and the low/avirulent HPR0 genotype (Table 1),
of which only about one third leads to different amino acids.
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and low-virulent isolates ISAV1 and ISAV11, and between
ISAV2 and ISAV9 (Table 1), and these were spread overseveral gene segments. In these cases, it is therefore tempting
to suggest that the variations in the HPR are of vital im-
portance for virulence. On the other hand, the two isolates
521T. Markussen et al. / Virology 374 (2008) 515–527ISAV4 and ISAV7 share identical HPRs, but differ signifi-
cantly in virulence. As they otherwise share relatively few
amino acid differences in their genomes (Table 1), this shows
that other genes may also be of importance in the virulence of
ISAV.
Discussion
In this work we provide evidence shedding light on the
mechanisms driving the evolution of ISAV. We present, for the
first time, the full-genome sequence of a low/avirulent ISAV
isolate not associated with classical ISA clinic or pathology,
displaying a full-length hemagglutinin-esterase (HE) gene; the
HPR0 genotype. Molecular and phylogenetic sequence
analyses of the coding regions of 12 ISAV genomes differing
in virulence provide evidence for the role of recombination and
reassortment in virulence. In particular, we provide evidence
for a new marker for virulence, next to one of the two potential
cleavage sites, R267, in the F protein: a Q266 (or in one case
H266) to L266 substitution seems to be a prerequisite for
virulence. It is assumed that this single amino acid mutation
may alter the recognition site and thereby the type of host
proteases that will cleave the F protein, although no obvious
switch in protease recognition pattern could be identified in
silico through analysis of known amino acid patterns
recognized by well-characterized proteases. As an alternative
to the Q266/H266→L266 substitution in the acquisition of
virulence, our data suggest that an insertion acquired by non-
homologous recombination, right upstream or downstream of
R267 is required, and that this site represents a recombinational
hot-spot.
Recombination in the F gene has recently been described in
seven ISAVisolates collected from field outbreaks during 2000–
2002 (Devold et al., 2006). One isolate displayed an insertion
positioned three amino acids upstream of R267, while the six
remaining isolates contained insertions at the same position as
found in ISAV3, two amino acids downstream of this site. Five
of the inserts were identical in sequence, including the presence
of Q266, while one isolate had a H266. However, the significance
of this in the virulence of ISAV has, for the first time, become
evident due to the availability of sequence information of the
low- or avirulent HPR0 genotype (SK779/06). We provide
evidence suggesting that insertion of a short amino acid stretch
in isolates containing Q266 or H266, probably resulting in altered
amino acid pattern around a putative cleavage site R267, leadsFig. 3. Sequence analyses of the recombination in gene segment 5 of ISAV3. A) A 30
5 (here illustrated by (+)RNA, although the event may occur on RNA strands of either
sites of the encoded fusion protein in ISAV3. Sequence homologies between the inse
colour (red or green). Relevant nucleotide positions, encoded amino acids in the one-l
all indicated. The amino acid sequence encoded by the insertion sequence is shown
from the reference isolate ISAV9 is included for comparisons. B) A phylogenetic
nucleotide substitution using multiple sequence alignment of the coding sequences o
partial segment 5 sequences acquired from GenBank. ISAV9 was used as root, and b
the neighbour-joining method and the F84 model of nucleotide substitution. To avoid
the ORFs were used. All F genes encoding the marker Q266, alternatively H266, are i
bold and underlined. Sequences having identical insertions to ISAV3 are marked wito acquisition of virulence. All isolates sequenced till today
associated with disease outbreaks carrying Q266/H266 contain an
insertion, while the Q266-carrying low- or avirulent SK779/06
does not.
The extensive sequence identity related to the recombination
event leading to the 10 amino acid insertion at position 268,
together with proposed mechanisms of recombination in RNA
viruses (reviewed in Nagy and Simon, 1997; Lai, 1992),
suggests that a switching of templates during viral replication
has occurred. Recombination may have occurred during
replication of RNA strands of either polarity, as there are
sequence similarities between the 5′ and 3′ end of the insert and
both regions flanking the site of insertion. In silico RNA
structure prediction analyses, using both negative sense (−) and
positive sense (+) viral RNA sequences, further suggests that
the insertion does not lead to a significant change in the
predicted RNA structure, which in turn could have impaired
viral replication (data not shown). Finally, phylogenetic
analyses of all available F (Fig. 3B) and HE genes (data not
shown) revealed that the seven 2000–2002 isolates were neither
closely related to nor contemporary with ISAV3, and that
identical recombination events have occurred at least twice
independently.
The relatively frequent occurrence of recombination in ISAV
contrasts with other members of the orthomyxovirus family,
where only a few cases of recombination have been documented
so far (Khatchikian et al., 1989; Orlich et al., 1994; Hirst et al.,
2004; Bergmann et al., 1992; Fields and Winter, 1982; Jennings
et al., 1983). Three of these events involve insertions in the HA
gene of subtype H7 of influenza Avirus, one or two amino acids
upstream of the HA1/HA2 cleavage site, and have been
associated with increased cleavage rate and pathogenicity
(Khatchikian et al., 1989; Orlich et al., 1994; Hirst et al.,
2004). The effect of the Q266/H266→L266 substitution or alter-
natively, recombination, close to the cleavage site may therefore
be analogous to the highly pathogenic influenza A viruses H5
and H7, where pathogenicity is acquired through the mutational
change of cleavage specificity from a trypsin-like to furin-like
recognition site following species crossover from waterfowl to
domesticated poultry (Bosch et al., 1981; Senne et al., 1996). In
addition, amino acids downstream of the cleavage site have also
been shown to be of importance for cleavability of the HA in
influenza A virus, (Horimoto and Kawaoka, 1995). Similar
changes have been described in the cleavage site of the F protein
of the avian paramyxovirus type 1 causing Newcastle disease innucleotide stretch, encoding 10 amino acids and located in the 5′-part of segment
polarity), was duplicated and inserted in close proximity to the putative cleavage
rt sequence and sequences surrounding the insertion site are shown in the same
etter code, and the location of the two putative cleavage sites in the F protein, are
in bold and the virulence marker L266/Q266 in blue colour. The F gene sequence
tree was constructed with maximum likelihood (ML) and the GTR model of
f segment 5 from ISAV1-11, SK779/06 (HPR0 genotype) and 57 other whole or
ootstrap values shown at selected nodes were calculated from 100 replicas using
gaps at the alignment ends, only the sequence parts stretching from nt 46-1356 in
n bold. Two genes without insertions but containing the Q266 marker are both in
th an asterisk.
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1992). In ISAV, it is not knownwhether cleavage of the F protein
occurs after R267 or K276, the two sites suggested by Aspehaug
et al. (2005).
The alterations at the cleavage site of the ISAV F protein,
together with deletions in the HE-HPR region probably
resulting in altered receptor-binding and -destroying activity,
most likely represent viral adaptation to Atlantic salmon leading
to disease in densely populated fish farms. This may raise the
question whether the reservoir for ISAV, previously suggested
to be wild salmonid fish (Plarre et al., 2005; Nylund et al., 2003;
Raynard et al., 2001), remains to be identified.
In orthomyxoviruses, reassortment of gene segments occurs
frequently and is a major contributor to the evolution of these
viruses and the emergence of new virulent strains (Guan et al.,
2003; Wallensten et al., 2005; McCullers et al., 2004;
Matsuzaki et al., 2003; Jones et al., 1987). The relative con-
tribution of reassortment in the evolution and virulence of
ISAV remains elusive. Our data indicate, however, that the
ISAV5 genotype is more virulent than those isolates whom it
forms monophyletic groups with in several gene segments,
although not segment 5 (ISAV8, ISAV10, ISAV11 and SK779/
06) (Mjaaland et al., 2005). This may suggest that reassort-
ment of segment 5 has contributed to the virulence of ISAV5.
Although amino acid differences present in the other gene
segments may contribute to virulence as well, the contribution
from gene segment 5 is strengthened by the three encoded
amino acid differences between ISAV5 and ISAV8/ISAV10/
ISAV11/SK779/06. More importantly, two of these differences
are located in close proximity of R267, and N263/S263 in par-
ticular can be expected to be part of a protease recognition
motif with cleavage at position 267. The potential additional
involvement in protease recognition and cleavage efficiency of
these mutations should therefore not be excluded as a factor
influencing the virulence of ISAV5, as compared to the low-
virulent isolates.
The limited sequence variability distributed throughout the
genomes of the ISAV isolates together with the preferred
substitutions to different amino acids, gives extra significance
to the changes actually present. Analyses of all protein
sequences encoded by SK779/06 and comparing with all
ISAVs of the present study, including results from protein blast
searches, revealed that only a few amino acid differences
encoded in the SK779/06 genome were unique for this isolate.
The majority of these were located in the polymerase genes,
and their potential involvement in viral replicative efficiency
should not be ruled out (Tumpey et al., 2005). Except for the
HE-HPR region, relatively few amino acid differences exist
between the high virulent isolate ISAV1 and SK779/06, and
between several other high and low-virulent isolates. This
probably reflects the importance of the HE-HPR region in
virulence of these isolates, in addition to the Q266/H266→L266
substitution in the F protein, which seems to be an absolute
prerequisite for virulence. On the other hand, isolates with
identical HE-HPR's, like ISAV4 and ISAV7, also vary
significantly in virulence, reflected by differences in their
ability to induce protective immune responses (Mjaaland et al.,2005). This case clearly illustrates that gene regions other than
the HE-HPR determine virulence. The highest percentages of
amino acid substitutions, as compared to the number of variable
nucleotide sites, were found in gene segments 7 and 8, and
most of these where placed in the proteins suggested to be
involved in interferon type I antagonism, likely to be involved
in virulence as well (McBeath et al., 2006; reviewed in Krug
et al., 2003; García-Rosado et al., in press). In conclusion, our
results indicate that highly parallel mechanisms for viral
adaption and virulence are operating between ISAV and avian
influenza A viruses.
Materials and methods
Virus strains
Eleven of the ISAV isolates (ISAV1-11) originate from
different regions along the Norwegian coast from the time
period 1989–1997 (Mjaaland et al., 2002, 2005), and represent
a collection of isolates differing highly in virulence, according
to a previously performed experimental trial using standar-
dised experimental fish (half-siblings with identical MHC
class I and II genotype) (Mjaaland et al., 2005). With the
exception of ISAV7, inducing the lowest overall mortality
(2.5%), the numbering in the remaining 10 isolates is directly
related to their virulence as determined by their induced
mortality; ISAV1 inducing highest mortality (46.8%) and
ISAV11 the lowest (3.8%) (Mjaaland et al., 2005). The low
virulence of ISAV7 and ISAV11 was most likely due to their
efficiency in inducing protective cellular immune responses
(Mjaaland et al., 2005). The twelfth isolate (SK779/06), with
the low- or avirulent HPR0 genotype, was detected in 2006 by
RT-PCR of tissues from farmed Atlantic salmon located in a
farm with no classical signs of ISA, although suffering from
signs of proliferative gill inflammation. Of the twenty-nine
fish tested from this population, only one tested ISAV (HPR0)
positive.
Viral RNA isolation
For isolation of RNA from the ISAV1-11 isolates, Atlantic
salmon kidney tissue from ISAV-diseased fish was homoge-
nized and used directly for inoculation onto salmon head kidney
cells (SHK-1) as described earlier (Dannevig et al., 1995;
Mjaaland et al., 2002). Culture supernatants were passed two or
three times. Maintaining (passaging) ISAV in a salmon cell line
for longer periods of time (up to a year), in between introducing
repeated freeze/thaw cycles has shown that the virus is very
resilient to mutational change in cell culture over time, as
monitored by its HE sequence (unpublished results from our
laboratory using ISAV4, the Norwegian reference isolate). In
addition, all isolates in this study, except for the HPR0 genotype
(SK779/06), had all been maintained in SHK-1 cells and
passaged 2–3 times prior to usage in an experimental trial (see
previous subsection) (Mjaaland et al., 2005). Viral RNA was
extracted from the final supernatants by using the QIAmp Viral
RNA Mini Kit (Qiagen). Due to the very low amount of viral
523T. Markussen et al. / Virology 374 (2008) 515–527RNA present in the HPR0-positive fish, and the lack of success
in attempts to culture this strain due to its avirulent/low-virulent
nature, total RNA was isolated directly from fish tissue using
RNeasy Mini Kit (Qiagen).
RT-PCR, cloning and sequencing
All viral gene segments were amplified by a two-step RT-
PCR. First-strand cDNA synthesis was carried out using seg-
ment specific forward primers (Table S1) or random hexamers
together with Superscript III reverse transcriptase (Invitrogen).
For the PCR reaction, 1–11 μl cDNA, segment specific primers
and Easy-A High Fidelity PCR Cloning Enzyme (Stratagene)
were used producing complete ORF's including initiation and
stopcodons (Table S1). For most segments also parts of the 5′
and 3′ non-translated regions were amplified. PCR cycling
conditions were 95 °C/2 min, followed by 35–38 cycles of
95 °C/40 s, 50 or 55 °C/30 s and 72 °C/1–2.5 min followed by a
final extension step at 72 °C/7 min. PCR products were resolved
by agarose gel electrophoresis, visualized by ethidium bromide
staining, purified using QIAquick Gel Extraction Kit (Qiagen)
and cloned into pCR2.1-TOPO/pCR4-TOPO according to the
manufacturer's protocol (Invitrogen). Plasmids from 3–6
positive clones per isolate were isolated from bacterial cultures
using the QIAprep Spin Miniprep Kit (Qiagen). Sequencing
was performed either by using an ABI PRISM Big Dye
Terminator Cycle Sequencing kit in an automatic sequencer
(ABI Prism 377), by capillary sequencing using the Mega-
BACE DYEnamic ET dye terminator kit (MegaBACE 500)
(Amersham), or plasmid DNA was sent to GATC-Biotech AG
(Konstanz, DE). If the sequencing data from the selected clones
proved inconclusive, additional clones were selected for
sequencing.
Due to the very low amounts of viral RNA present in the
HPR0-positive fish tissues, the only way to obtain the complete
coding sequences of the SK779/06 HPR0 isolate was to produce
small overlapping PCR fragments, ranging from 287 bp to
804 bp in size (Table S1). Moreover, to obtain sufficient
amounts of PCR product needed for sequencing, nested PCR
was performed on each of the reactions. The two-step RT-PCR
and agarose gel purification were performed as described above.
Nested PCR was performed on 1–2 μl of purified PCR product
from the first PCR reaction. PCR cycling conditions were as
described above, except for an annealing temperature of 52 °C,
and 40 amplification cycles. In a number of cases PCRs were
repeated with cDNAs from separate RT-reactions for further
sequence verification. Purified nested PCR products were sent
to GATC-Biotech AG for sequencing.
Phylogenetic analyses
Multiple sequence alignments of the coding regions of all the
eight ISAV gene segments were performed in AlignX (Vector
NTI Advance™ 9 package, InforMax, Inc.) and BioEdit (Tom
Hall, Ibis Therapeutics). Phylogenetic analyses were performed
by maximum likelihood (ML) using the program PHYML
(Guindon and Gascuel, 2003) (available at http://phylemon.bioinfo.cipf.es/cgi-bin/phyml.cgi). FindModel (http://hcv.lanl.
gov/content/hcv-db/findmodel/findmodel.html) (developed
from a Modeltest script, by Posada and Crandall, 1998), to-
gether with pair wise comparisons of nucleotide substitution
models using likelihood ratio tests (LRTs), was used to
determine the most appropriate model. As a consequence, the
GTR model was chosen in all phylogenetic analyses, as it
produced the highest likelihood scores (lnL values) of all the
substitution models available in PHYML, being significantly
better than the other models in LRT for some of the segments.
Bootstrap values in the trees were calculated from neighbour-
joining analyses and 100 replicas using the programs seqboot,
dnadist and neighbour (F84) implemented in the PHYLIP 3.65
package (Felsenstein, 2005). All trees were drawn using
MEGA4 software (Tamura et al., 2007) (available at http://
www.megasoftware.net/) and rooted to the reference isolate
ISAV9 whose genomic sequence is highly similar to the
consensus sequence from multiple sequence alignment of all
coding regions in the genomes of the 12 ISAV isolates. The
HPR region in segment 6 which lies between positions 985 and
1114 when aligned according to the HPR0 genotype (SK779/
06), and a 30-nucleotide insert only present in segment 5 of
ISAV3, was excluded from the sequence alignments as adequate
evolutionary models for deletions or insertions are not available
and therefore not included in software for phylogenetic
analyses. Mostly, bootstrap values set above 80 were used as
cut-off value to indicate close relationship between virus
isolates. In some cases though, due to the highly conserved
nature of the ISAV genome, lower values combined with
detailed sequence analysis was used to depict common origins
between gene segments.
GenBank accession numbers
The nucleotide sequences obtained in this study have the
following accession numbers in GenBank: DQ785175–
DQ785286 and EU118815–EU118822.
Computer analyses
Protein blast searches (http://www.ncbi.nlm.nih.gov/BLAST/)
and nucleotide blast (blastn) searches (http://www.ncbi.nlm.nih.
gov/BLAST/) were conducted using ISAV9 coding sequences
as query. RNA secondary structure predictions of viral (−)RNA
and (+)RNA were performed using the Mfold program (version
3.2) (Zuker, 2003; Walter et al., 1994). Default parameters were
used in the predictions with the exception of temperature, which
was set to 15 °C. PeptideCutter (http://au.expasy.org/tools/
peptidecutter/) was used in the search for potential protease
cleavage sites or motives in the fusion protein (Gasteiger et al.,
2003).
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Table S1
Primers used to amplify the open reading frames (ORF's) from the genomes of ISAV1 to ISAV11 and SK779/06 (HPR0 genotype)Genomic segments and gene product(s) Primer name Primer sequence (5′–3′) and binding sites relative to ORF'sSegment 1 (PB2) ORFseg1-Fa C(−9)AGCTAAGAATGGACTTTATATCAG
ORFseg1-Ra G(+24)CAATATTGACCAACACTCA
s1Fb CACCATGGACTTTATATCAGAAAACAC
s1IntRb CACCACCTTCTGAGACATGTTGAT
s1IntFb CAACTACCGAGGAGTACTGGAATGT
s1IntR2b GTGTGTGTTCTCAGGCTTTCCA
s1IntF2b GTCAAGAACACGTCAATAGACAGGAT
s1IntR3b TTATGTCCACCCCTGTGTTTTCT
s1IntF3b AGAGTCTGTACGAAAAGGCAACCT
s1IntR4b CTACCTGTTGCCATCTTCTCCAT
s1IntF4b GGAGAGGTGTATGAAGAGAGGTCAAA
s1Rb TTAAACACCATATTCATCCATCAGGTSegment 2 (PB1) ORFseg2-Fa C(−15)GCTCTTTAATAACCATGGAAAC
ORFseg2-Ra G(+24)GGTATATACACCATCACAC
s2Fb CACCATGGAAACTCTAGTAGGTGGG
s2IntRb GTTTCCATATGTATCCTTTCACTTCTTGT
s2IntFb CAGAGGAAGAACCATGTCAGACC
s2IntR2b GCTACTGGTTTGACACTTTTTTGAGA
s2IntF2b TTTCCTAAGAGAACTTGGGATAAAGG
s2IntR3b TAAGAGCCATTTCGAGTCTTTGTCTT
s2IntF3b CAGTTTCACACCTGAGGCAGTGTA
s2IntR4b CTTTGAGTGCAATTCCATCGAAA
s2IntF4b AGAGACAATGTCTATACCTGAGAGCAT
s2Rb TCAAACATGCTTTTTCTTCTTAATCASegment 3 (NP) ORFseg3-Fa C(−10)GTATAAGAGATGGCCGATA
ORFseg3-Ra C(+77)CCAAACCCAATTATATCATAG
s3Fb CACCATGGCCGATAAAGGTATG
s3IntRb TTGCCTCTTTCCGTCTTCATC
s3IntFb AAGGTGAAATGAGCATCTGG
s3IntR2b CTGGTCTGCTGACAACACTGACT
s3IntF2b AGGATCAAAGGCAACTGAATCAAG
s3IntR3b ACACATGTTCTAGCCACAGACATT
s3IntF3b TCAGTGTTGGCAATGGACTTCAT
s3IntR4b CCTGATAGCGCCTTGGTTGA
s3IntF4b GCTGAGGCTGTCCAATGTGAA
s3Rb TTTCAAATGTCAGTGTCTTCCTCCTSegment 4 (PA) ORFseg4-Fa C(−4)AAGATGGATAACCTCCGTG
ORFseg4-Ra C(+1)TCATTGGGTACTGACTGCA
s4Fb CACCATGGATAACCTCCGTGAA
s4IntRb TGATTGATCTTCATTGGTATTCCAT
s4IntFb GGGTCTAGTCGAAACAGGAGTT
s4IntR2b AGCAGCAATTCTTGCAGGAAGT
s4IntF2b CGCAGTTCTGTGAAATTGATGAA
s4IntR3b AGTTGCTGTGCCATCCAGTC
s4IntF3b GGAGACACAAGAAAGGAAGGATACT
s4Rb TTATTGGGTACTGACTGCAATTTTCSegment 5 (F) ORFseg5-Fa A(+1)TGGCTTTTCTAACAATTTTA
ORFseg5-Ra T(0)TATCTCCTAATGCATCCC
s5Fb CACCATGGCTTTTCTAACAATTT
s5IntRb CCCTACCAAGGACAACATCATGTCG
s5IntFb GAAGCAGACTTGAGGATTCA
s5IntR2b TTCACCTTGTTGATCTGGTCTA
s5IntF2b AGCATCCGCAGAAGATGTGAA
s5Rb TTATCTTCTAATGCATCCCCACAGSegment 6 (HE) ORFseg6-Fa GGGCTAGCA(+1)TGGCACGATTCATAATT
ORFseg6-Ra GGGGTACCGTA(−3)GCAACAGACAGGCTCGAT
s6Fb CACCATGGCACGATTCATAATTT
s6IntRb CTTCAAAGGTGTCTGACACGTA
s6IntFb GGAATCTACAAGGTCTGCATTG
s6Rb TTAAGCAACAGACAGGCTCGATG
Table S1 (continued )
525T. Markussen et al. / Virology 374 (2008) 515–527Genomic segments and gene product(s) Primer name Primer sequence (5′–3′) and binding sites relative to ORF'sSegment 7 ORF1 (non-structural) Seg7-Fa TATTGGTCTCAGGGA(−21)GCTAAGATTCTCCT
Seg7-Ra ATATGGTCTCGTATTA(−100)GTAAAAATTCTCCTTTTSegment 7 ORF2 (putative nuclear export protein) s7Fb CACCATGGATTTCACCAAAGTGTA
s7IntRb GAAAATCCATGTTCTCAGATGCAA
s7IntFb TGGGATCATGTGTTTCCTGCTA
s7Rb TTAATTCTCATTACAAATGTATTTTTCSegment 8 ORF1 (M protein) Seg8-Fa TATTCGTCTCAGGGA(−21)GCAAAGATTGGCTA
Seg8-Ra ATATCGTCTCGTATTA(+145)GTAAAAAAAGGCTTTTTSegment 8 ORF2 (structural protein) s8Fb CACCATGAACGAATCACAATGGA
s8IntRb GTAGCATTGTCTTCAGGTCCTTCAA
s8IntFb AAAGTGGGCAATGGTGTATGGTA
s8Rb TTATTGTACAGAGTCTTCCAATTGGTCaPrimers amplifying the complete ORFs of ISAV1–ISAV11 using two-step RT-PCR. The majority of these primers are wholly or partially located to the non-
translated regions of each gene segment, and the position numbering (subscript numbers) is for forward primers relative to coding sequence(start), and for reverse
primers to coding sequence(end).
bPrimers used to amplify the ORFs from SK779/06 (HPR0 genotype). All bind to translated regions and were designed to produce small overlapping fragments of
coding sequence ranging from 287 bp to 804 bp in size. Amplification was performed using two-step RT-PCR, followed by nested PCR. For all primers the segment
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